Literature DB >> 23358967

Outpatient therapy for fever and neutropenia is safe but implementation is the key.

Monica A Slavin, Karin A Thursky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358967     DOI: 10.1200/JCO.2012.47.5905

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy.

Authors:  Caitriona B O'Neill; Coral L Atoria; Eileen M O'Reilly; Martin C Henman; Peter B Bach; Elena B Elkin; Caitriona B O'Neill; Coral L Atoria; Eileen M O'Reilly; Martin C Henman; Peter B Bach; Elena B Elkin
Journal:  J Oncol Pract       Date:  2016-02       Impact factor: 3.840

2.  Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.

Authors:  Gabrielle M Haeusler; Karin A Thursky; Monica A Slavin; Franz E Babl; Richard De Abreu Lourenco; Zoe Allaway; Francoise Mechinaud; Robert Phillips
Journal:  EClinicalMedicine       Date:  2020-01-07

3.  Managing low-risk febrile neutropenia in children in the time of COVID-19: What matters to parents and clinicians.

Authors:  Gabrielle M Haeusler; Richard De Abreu Lourenco; Cindy Bakos; Tracey O'Brien; Monica A Slavin; Julia E Clark; Brendan McMullan; Meredith L Borland; Franz E Babl; Meinir Krishnasamy; Marijana Vanevski; Karin A Thursky; Lisa Hall
Journal:  J Paediatr Child Health       Date:  2021-02-03       Impact factor: 1.929

4.  Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia.

Authors:  Marcel Doerflinger; Gabrielle M Haeusler; Connie S N Li-Wai-Suen; Julia E Clark; Monica Slavin; Franz E Babl; Zoe Allaway; Francoise Mechinaud; Gordon K Smyth; Richard De Abreu Lourenco; Bob Phillips; Marc Pellegrini; Karin A Thursky
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.